- Delivery Method:
- VIA Electronic Mail
Recipient NameRaymond L. Solano
- Prescription Dispensing Laboratories Inc.
101 Commercial Parkway
Cedar Park, TX 78613
- Issuing Office:
- Division of Pharmaceutical Quality Operations II
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [Case # 579286; Dated: July 30, 2019]. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
If you have questions regarding the contents of this letter, you may contact John Diehl via phone at 214-253-5288 or email at firstname.lastname@example.org.
John W. Diehl, M.S
Director, Compliance Branch
Office of Pharmaceutical Quality Operations, Division II